tiprankstipranks
ESSA Pharma Inc. (EPIX)
:EPIX
US Market

ESSA Pharma (EPIX) Income Statement

Compare
273 Followers

ESSA Pharma Income Statement

Last quarter (Q1 2025), ESSA Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, ESSA Pharma's net income was $-8.53M. See ESSA Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -118.49K$ -121.79K$ -109.46K$ -110.32K
Operating Expenses
$ 21.21M$ 32.13M$ 36.96M$ 37.14M$ 23.52M
Depreciation and Amortization
$ 0.00$ 118.49K$ 121.79K$ 109.46K$ 110.32K
EBITDA
$ 0.00$ -26.46M$ -35.08M$ -36.71M$ -23.01M
Operating Income
$ 0.00$ -32.13M$ -35.34M$ -36.91M$ -23.12M
Other Income/Expenses
$ 0.00$ 5.55M$ 1.74M$ 303.76K$ -214.10K
Pretax Income
$ 0.00$ -26.58M$ -35.22M$ -36.84M$ -23.73M
Net Income
$ 0.00$ -26.58M$ -35.10M$ -36.81M$ -23.45M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.64$ -0.60$ -0.80$ -0.96$ -1.04
Diluted EPS
$ -0.64$ -0.60$ -0.80$ -0.96$ -1.04
Weighted Average Shares Outstanding
44.28M 44.09M 44.04M 38.48M 22.44M
Weighted Average Shares Outstanding (Diluted)
44.28M 44.09M 44.04M 38.48M 22.44M
Currency in USD

ESSA Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis